Covestor LTD Mirati Therapeutics, Inc. Transaction History

Covestor LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$41.99 - $62.38 $41 - $62	-1 Reduced 0.53%	188 $11,000
Q3 2023 Nov 13, 2023	SELL	$27.8 - $45.35 $27 - $45	-1 Reduced 0.53%	189 $8,000
Q2 2023 Aug 11, 2023	SELL	$36.13 - $49.49 $36 - $49	-1 Reduced 0.52%	190 $7,000
Q1 2023 May 15, 2023	BUY	$36.54 - $54.26 $1,278 - $1,899	35 Added 22.44%	191 $7,000
Q4 2022 Feb 13, 2023	BUY	$41.27 - $98.62 $6,314 - $15,088	153 Added 5100.0%	156 $7,000
Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $178 - $260	3 New	3 $0
Q2 2022 Aug 10, 2022	SELL	$39.16 - $88.71 $39 - $88	-1 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$132.01 - $190.29 $132 - $190	1 New	1 $0

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

Stay updated on Covestor LTD with notifications on news.